Ask a Cancer Researcher: What is a biomarker?

What happens when I donate my tissue for research?

Ask a Cancer Researcher: How can we predict if breast cancer will come back?

New directors of OICR Diagnostic Development program set sights on bringing discoveries to the clinic

New funding from the Ontario Institute for Cancer Research supports projects developing methods for cancer detection and tools to facilitate better treatment decisions for high-risk cancer patients

Largest study of its kind informs treatment of breast cancer in men

OICR research team awarded $2.4 million to facilitate precision medicine for early-stage breast cancer

Bridging the GAPP: Bringing new diagnostic tests to patients

Harnessing the time before a patient’s surgery to accelerate cancer research

Using the “window of opportunity” to understand biomarkers and tumour biology

Canadian Government-Sponsored Collaboration Targets Standardized Cancer Testing

Tumour samples and ultra-low temperatures

Sometimes the simpler, the better: bringing personalized treatment selection for bladder cancer closer to the clinic 

An inside look at OICR’s Tissue Portal

Researchers investigated almost 200,000 cases of breast cancer: Here's what they found

Breaking down barriers to translation: A case of standardization in digital pathology

Meet the researchers: Cheryl Crozier

New guidelines for HER2 testing in breast cancer

Large-scale study provides clearer picture of recurrence risk for ER-positive breast cancer

OICR launches Tissue Portal to support tissue-based research projects

Could diagnosing cancer as rare diseases improve outcomes for patients?

Open resource: How we’re making our research resources more accessible to the community

OICR is making its technology infrastructure, expertise and resources more available to the Ontario cancer community